← Back to Search

Antigen Test

At least 30 children between 2 - 13 years of age for COVID-19

N/A
Waitlist Available
Led By Enrique Villa, MD
Research Sponsored by BioTeke USA, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights

Study Summary

This trialwill test the accuracy of a home COVID-19 test compared to a lab test, to see if it can be used safely in homes.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Negative Percent Agreement - Specificity
Positive Percent Agreement - Sensitivity

Trial Design

2Treatment groups
Experimental Treatment
Group I: Subjects 14 - 90 years of ageExperimental Treatment3 Interventions
The subject will self collect and test using the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.
Group II: At least 30 children between 2 - 13 years of ageExperimental Treatment3 Interventions
Subjects less than 14 years of age, where the Parent or legal guardian collects a sample from their child (e.g., ages 2-13) and performs the Bio-Self COVID-19 antigen home test. The standard of care test and the RT-PCR test samples will be collected by the study team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bio-Self COVID-19 Antigen Home Test
2022
N/A
~290
Standard of Care COVID-19 Test
2022
N/A
~290
RT-PCR Test
2022
N/A
~1600

Find a Location

Who is running the clinical trial?

BioTeke USA, LLCLead Sponsor
CSSi Life SciencesIndustry Sponsor
6 Previous Clinical Trials
393 Total Patients Enrolled
4 Trials studying COVID-19
334 Patients Enrolled for COVID-19
Enrique Villa, MDPrincipal InvestigatorL&A Morales Healthcare
1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying COVID-19
30 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~97 spots leftby Apr 2025